EGFR c.1476C>G ;(p.S492R)

Variant ID: 7-55228009-C-G

NM_005228.3(EGFR):c.1476C>G;(p.S492R)

This variant was identified in 121 publications

View GRCh38 version.




Publications:


Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.

World Journal Of Gastroenterology
Ren, Sheng-Nan SN; Zhang, Zhan-Yi ZY; Guo, Rui-Jie RJ; Wang, Da-Ren DR; Chen, Fang-Fang FF; Chen, Xue-Bo XB; Fang, Xue-Dong XD
Publication Date: 2023-04-07

Variant appearance in text: EGFR: S492R
PubMed Link: 37155531
Variant Present in the following documents:
  • WJG-29-1911.pdf
View BVdb publication page



Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on RAS Mutation.

Cancers
Udagawa, Shohei S; Ooki, Akira A; Shinozaki, Eiji E; Fukuda, Koshiro K; Yamaguchi, Kensei K; Osumi, Hiroki H
Publication Date: 2023-02-25

Variant appearance in text: EGFR: S492R
PubMed Link: 36900264
Variant Present in the following documents:
  • Main text
  • cancers-15-01473.pdf
View BVdb publication page



A study of gene variation in All-RAS wild-type metastatic colorectal cancer and its correlation with cetuximab.

Journal Of Gastrointestinal Oncology
Tao, Huimin H; Shen, Meng M; Zhang, Xiaochang X; Wang, Minghui M; Wu, Yan Y; Sun, Hui H; Ling, Chen C; Yang, Ying Y; Chen, Kai K; Li, Dapeng D
Publication Date: 2022-12

Variant appearance in text: EGFR: S492R
PubMed Link: 36636055
Variant Present in the following documents:
  • Main text
  • jgo-13-06-3009.pdf
View BVdb publication page



Current concepts of anti-EGFR targeting in metastatic colorectal cancer.

Frontiers In Oncology
Doleschal, Bernhard B; Petzer, Andreas A; Rumpold, Holger H
Publication Date: 2022

Variant appearance in text: EGFR: S492R
PubMed Link: 36465407
Variant Present in the following documents:
  • Main text
  • fonc-12-1048166.pdf
View BVdb publication page



Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies.

Frontiers In Oncology
Bergado-Báez, Gretchen G; Gonzalez Suarez, Narjara N; García, Lisset Chao LC; Pérez-Martínez, Dayana D; Hernández-Fernández, Diana Rosa DR; Fundora-Barrios, Talia T; Rodríguez-Álvarez, Antonio A; Díaz-Ordaz, Geidy Diana GD; Lindzen, Moshit M; Yarden, Yosef Y; Sánchez-Ramírez, Belinda B
Publication Date: 2022

Variant appearance in text: EGFR: S492R
PubMed Link: 36408164
Variant Present in the following documents:
  • fonc-12-951267.pdf
View BVdb publication page



Molecular targeted therapy for anticancer treatment.

Experimental & Molecular Medicine
Min, Hye-Young HY; Lee, Ho-Young HY
Publication Date: 2022-10

Variant appearance in text: EGFR: S492R
PubMed Link: 36224343
Variant Present in the following documents:
  • Main text
  • 12276_2022_Article_864.pdf
View BVdb publication page



Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.

Journal Of Hematology & Oncology
Wu, Qing Q; Qian, Wei W; Sun, Xiaoli X; Jiang, Shaojie S
Publication Date: 2022-10-08

Variant appearance in text: EGFR: S492R
PubMed Link: 36209184
Variant Present in the following documents:
  • Main text
View BVdb publication page



Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance.

Nature Communications
Zhuang, Xinlei X; Wang, Zhe Z; Fan, Jiansheng J; Bai, Xuefei X; Xu, Yingchun Y; Chou, James J JJ; Hou, Tingjun T; Chen, Shuqing S; Pan, Liqiang L
Publication Date: 2022-07-30

Variant appearance in text: EGFR: S492R
PubMed Link: 35907884
Variant Present in the following documents:
  • 41467_2022_32159_MOESM10_ESM.xlsx, sheet 4
View BVdb publication page



AACR Project GENIE: 100,000 Cases and Beyond.

Cancer Discovery
Pugh, Trevor J TJ; Bell, Jonathan L JL; Bruce, Jeff P JP; Doherty, Gary J GJ; Galvin, Matthew M; Green, Michelle F MF; Hunter-Zinck, Haley H; Kumari, Priti P; Lenoue-Newton, Michele L ML; Li, Marilyn M MM; Lindsay, James J; Mazor, Tali T; Ovalle, Andrea A; Sammut, Stephen-John SJ; Schultz, Nikolaus N; Yu, Thomas V TV; Sweeney, Shawn M SM; Bernard, Brady B; ,
Publication Date: 2022-09-02

Variant appearance in text: EGFR: S492R
PubMed Link: 35819403
Variant Present in the following documents:
  • cd-21-1547_supplementary_table_1_suppst1.xlsx, sheet 1
View BVdb publication page



Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches.

Frontiers In Oncology
Emran, Talha Bin TB; Shahriar, Asif A; Mahmud, Aar Rafi AR; Rahman, Tanjilur T; Abir, Mehedy Hasan MH; Siddiquee, Mohd Faijanur-Rob MF; Ahmed, Hossain H; Rahman, Nova N; Nainu, Firzan F; Wahyudin, Elly E; Mitra, Saikat S; Dhama, Kuldeep K; Habiballah, Mahmoud M MM; Haque, Shafiul S; Islam, Ariful A; Hassan, Mohammad Mahmudul MM
Publication Date: 2022

Variant appearance in text: EGFR: S492R
PubMed Link: 35814435
Variant Present in the following documents:
  • Main text
  • fonc-12-891652.pdf
View BVdb publication page



Drug Resistance in Colorectal Cancer: From Mechanism to Clinic.

Cancers
Wang, Qianyu Q; Shen, Xiaofei X; Chen, Gang G; Du, Junfeng J
Publication Date: 2022-06-14

Variant appearance in text: EGFR: S492R
PubMed Link: 35740594
Variant Present in the following documents:
  • Main text
  • cancers-14-02928.pdf
View BVdb publication page



Drug-adapted cancer cell lines as preclinical models of acquired resistance.

Cancer Drug Resistance (Alhambra, Calif.)
Michaelis, Martin M; Wass, Mark N MN; Cinatl, Jindrich J
Publication Date: 2019

Variant appearance in text: EGFR: S492R
PubMed Link: 35582596
Variant Present in the following documents:
  • cdr-2-447.pdf
View BVdb publication page



Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab.

International Journal Of Cancer
Martini, Giulia G; Ciardiello, Davide D; Dallio, Marcello M; Famiglietti, Vincenzo V; Esposito, Lucia L; Corte, Carminia Maria Della CMD; Napolitano, Stefania S; Fasano, Morena M; Gravina, Antonietta Gerarda AG; Romano, Marco M; Loguercio, Carmelina C; Federico, Alessandro A; Maiello, Evaristo E; Tuccillo, Concetta C; Morgillo, Floriana F; Troiani, Teresa T; Di Maio, Massimo M; Martinelli, Erika E; Ciardiello, Fortunato F
Publication Date: 2022-08-01

Variant appearance in text: EGFR: S492R
PubMed Link: 35429341
Variant Present in the following documents:
  • Main text
  • IJC-151-473.pdf
View BVdb publication page



Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes.

Diagnostics (Basel, Switzerland)
Long-Mira, Elodie E; Picard-Gauci, Alexandra A; Lassalle, Sandra S; Hofman, Véronique V; Lalvée, Salomé S; Tanga, Virginie V; Zahaf, Katia K; Bonnetaud, Christelle C; Lespinet, Virginie V; Camuzard, Olivier O; Montaudié, Henri H; Poissonnet, Gilles G; Passeron, Thierry T; Ilié, Marius M; Hofman, Paul P
Publication Date: 2022-03-19

Variant appearance in text: EGFR: S492R
PubMed Link: 35328303
Variant Present in the following documents:
  • diagnostics-12-00751.pdf
View BVdb publication page



Systematic review and meta-analysis of genomic alterations in acral melanoma.

Pigment Cell & Melanoma Research
Broit, Natasa N; Johansson, Peter A PA; Rodgers, Chloe B CB; Walpole, Sebastian T ST; Hayward, Nicholas K NK; Pritchard, Antonia L AL
Publication Date: 2022-05

Variant appearance in text: EGFR: S492R
PubMed Link: 35229492
Variant Present in the following documents:
  • PCMR-35-369-s003.xlsx, sheet 12
View BVdb publication page



The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Nature Cancer
Tamborero, David D; Dienstmann, Rodrigo R; Rachid, Maan Haj MH; Boekel, Jorrit J; Lopez-Fernandez, Adria A; Jonsson, Markus M; Razzak, Ali A; Braña, Irene I; De Petris, Luigi L; Yachnin, Jeffrey J; Baird, Richard D RD; Loriot, Yohann Y; Massard, Christophe C; Martin-Romano, Patricia P; Opdam, Frans F; Schlenk, Richard F RF; Vernieri, Claudio C; Masucci, Michele M; Villalobos, Xenia X; Chavarria, Elena E; , ; Balmaña, Judith J; Apolone, Giovanni G; Caldas, Carlos C; Bergh, Jonas J; Ernberg, Ingemar I; Fröhling, Stefan S; Garralda, Elena E; Karlsson, Claes C; Tabernero, Josep J; Voest, Emile E; Rodon, Jordi J; Lehtiö, Janne J
Publication Date: 2022-02

Variant appearance in text: EGFR: Ser492Arg
PubMed Link: 35221333
Variant Present in the following documents:
  • 43018_2022_332_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies.

Cancers
Rachiglio, Anna Maria AM; Forgione, Laura L; Pasquale, Raffaella R; Barone, Carlo Antonio CA; Maiello, Evaristo E; Antonuzzo, Lorenzo L; Cassata, Antonino A; Tonini, Giuseppe G; Bordonaro, Roberto R; Rosati, Gerardo G; Zaniboni, Alberto A; Lonardi, Sara S; Ferrari, Daris D; Frassineti, Giovanni Luca GL; Tamberi, Stefano S; Pisconti, Salvatore S; Di Fabio, Francesca F; Roma, Cristin C; Orlandi, Armando A; Latiano, Tiziana T; Damato, Angela A; Tortora, Giampaolo G; Pinto, Carmine C; Normanno, Nicola N
Publication Date: 2022-02-18

Variant appearance in text: EGFR: S492R
PubMed Link: 35205799
Variant Present in the following documents:
  • Main text
  • cancers-14-01052.pdf
View BVdb publication page



Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer.

Frontiers In Oncology
Chu, Jinjin J; Fang, Xianzhu X; Sun, Zhonghou Z; Gai, Linlin L; Dai, Wenqing W; Li, Haibo H; Yan, Xinyi X; Du, Jinke J; Zhang, Lili L; Zhao, Lu L; Xu, Donghua D; Yan, Shushan S
Publication Date: 2021

Variant appearance in text: EGFR: S492R
PubMed Link: 35111681
Variant Present in the following documents:
  • Main text
  • fonc-11-801319.pdf
View BVdb publication page



LncRNA UCA1 mediates Cetuximab resistance in Colorectal Cancer via the MiR-495 and HGF/c-MET Pathways.

Journal Of Cancer
Yuan, Heng-Heng HH; Zhang, Xin-Chen XC; Wei, Xiao-Li XL; Zhang, Wen-Jie WJ; Du, Xiao-Xue XX; Huang, Peng P; Chen, Hao H; Bai, Lu L; Zhang, Hong-Feng HF; Han, Yu Y
Publication Date: 2022

Variant appearance in text: EGFR: S492R
PubMed Link: 34976187
Variant Present in the following documents:
  • Main text
  • jcav13p0253.pdf
View BVdb publication page



A full-proteome, interaction-specific characterization of mutational hotspots across human cancers.

Genome Research
Chen, Siwei S; Liu, Yuan Y; Zhang, Yingying Y; Wierbowski, Shayne D SD; Lipkin, Steven M SM; Wei, Xiaomu X; Yu, Haiyuan H
Publication Date: 2022-01

Variant appearance in text: EGFR: S492R
PubMed Link: 34963661
Variant Present in the following documents:
  • supp_gr.275437.121_Supplementary_Table_1.xlsx, sheet 3
View BVdb publication page



The Role of EREG/EGFR Pathway in Tumor Progression.

International Journal Of Molecular Sciences
Cheng, Wan-Li WL; Feng, Po-Hao PH; Lee, Kang-Yun KY; Chen, Kuan-Yuan KY; Sun, Wei-Lun WL; Van Hiep, Nguyen N; Luo, Ching-Shan CS; Wu, Sheng-Ming SM
Publication Date: 2021-11-27

Variant appearance in text: EGFR: S492R
PubMed Link: 34884633
Variant Present in the following documents:
  • Main text
View BVdb publication page



The Role of EREG/EGFR Pathway in Tumor Progression.

International Journal Of Molecular Sciences
Cheng, Wan-Li WL; Feng, Po-Hao PH; Lee, Kang-Yun KY; Chen, Kuan-Yuan KY; Sun, Wei-Lun WL; Van Hiep, Nguyen N; Luo, Ching-Shan CS; Wu, Sheng-Ming SM
Publication Date: 2021-11-27

Variant appearance in text: EGFR: S492R
PubMed Link: 34884633
Variant Present in the following documents:
  • Main text
View BVdb publication page



Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy.

Cancers
Ciardiello, Davide D; Famiglietti, Vincenzo V; Napolitano, Stefania S; Esposito, Lucia L; Normanno, Nicola N; Avallone, Antonio A; Latiano, Tiziana T; Maiello, Evaristo E; Pietrantonio, Filippo F; Cremolini, Chiara C; Santabarbara, Giuseppe G; Pinto, Carmine C; Troiani, Teresa T; Martinelli, Erika E; Ciardiello, Fortunato F; Martini, Giulia G
Publication Date: 2021-11-15

Variant appearance in text: EGFR: S492R
PubMed Link: 34830870
Variant Present in the following documents:
  • Main text
  • cancers-13-05715.pdf
View BVdb publication page



The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Lee, Jessica K JK; Hazar-Rethinam, Mehlika M; Decker, Brennan B; Gjoerup, Ole O; Madison, Russell W RW; Lieber, Daniel S DS; Chung, Jon H JH; Schrock, Alexa B AB; Creeden, James J; Venstrom, Jeffrey J; Alexander, Brian B; Oxnard, Geoffrey R GR
Publication Date: 2022-02-15

Variant appearance in text: EGFR: S492R
PubMed Link: 34753780
Variant Present in the following documents:
  • Main text
  • 728.pdf
View BVdb publication page



Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies.

Journal Of Experimental & Clinical Cancer Research : Cr
Zhou, Jing J; Ji, Qing Q; Li, Qi Q
Publication Date: 2021-10-18

Variant appearance in text: EGFR: S492R
PubMed Link: 34663410
Variant Present in the following documents:
  • Main text
  • 13046_2021_Article_2130.pdf
View BVdb publication page



Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives.

Cancers
Moati, Emilie E; Taly, Valerie V; Garinet, Simon S; Didelot, Audrey A; Taieb, Julien J; Laurent-Puig, Pierre P; Zaanan, Aziz A
Publication Date: 2021-09-22

Variant appearance in text: EGFR: S492R
PubMed Link: 34638228
Variant Present in the following documents:
  • Main text
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: EGFR: S492R
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Tackling Refractory Metastatic Colorectal Cancer: Future Perspectives.

Cancers
Personeni, Nicola N; Smiroldo, Valeria V; Giunta, Emilio Francesco EF; Prete, Maria Giuseppina MG; Rimassa, Lorenza L; Bregni, Giacomo G; Sclafani, Francesco F
Publication Date: 2021-09-07

Variant appearance in text: EGFR: S492R
PubMed Link: 34572729
Variant Present in the following documents:
  • Main text
  • cancers-13-04506.pdf
View BVdb publication page



Pharmacogenomics in colorectal cancer: current role in clinical practice and future perspectives.

Journal Of Cancer Metastasis And Treatment
Battaglin, Francesca F; Puccini, Alberto A; Naseem, Madiha M; Schirripa, Marta M; Berger, Martin D MD; Tokunaga, Ryuma R; McSkane, Michelle M; Khoukaz, Taline T; Soni, Shivani S; Zhang, Wu W; Lenz, Heinz-Josef HJ
Publication Date: 2018

Variant appearance in text: EGFR: S492R
PubMed Link: 34532592
Variant Present in the following documents:
  • Main text
View BVdb publication page



A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models.

Signal Transduction And Targeted Therapy
Fan, Jiansheng J; Zhuang, Xinlei X; Yang, Xiaoyue X; Xu, Yingchun Y; Zhou, Zhan Z; Pan, Liqiang L; Chen, Shuqing S
Publication Date: 2021-09-03

Variant appearance in text: EGFR: S492R
PubMed Link: 34475375
Variant Present in the following documents:
  • Main text
  • 41392_2021_Article_666.pdf
View BVdb publication page



A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models.

Signal Transduction And Targeted Therapy
Fan, Jiansheng J; Zhuang, Xinlei X; Yang, Xiaoyue X; Xu, Yingchun Y; Zhou, Zhan Z; Pan, Liqiang L; Chen, Shuqing S
Publication Date: 2021-09-03

Variant appearance in text: EGFR: S492R
PubMed Link: 34475375
Variant Present in the following documents:
  • Main text
  • 41392_2021_Article_666.pdf
View BVdb publication page



Colorectal Cancer: From Genetic Landscape to Targeted Therapy.

Journal Of Oncology
El Bali, Mouade M; Bakkach, Joaira J; Bennani Mechita, Mohcine M
Publication Date: 2021

Variant appearance in text: EGFR: S492R
PubMed Link: 34326875
Variant Present in the following documents:
  • Main text
View BVdb publication page



Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.

Genome Medicine
Vangala, Deepak D; Ladigan, Swetlana S; Liffers, Sven T ST; Noseir, Soha S; Maghnouj, Abdelouahid A; Götze, Tina-Maria TM; Verdoodt, Berlinda B; Klein-Scory, Susanne S; Godfrey, Laura L; Zowada, Martina K MK; Huerta, Mario M; Edelstein, Daniel L DL; de Villarreal, Jaime Martinez JM; Marqués, Miriam M; Kumbrink, Jörg J; Jung, Andreas A; Schiergens, Tobias T; Werner, Jens J; Heinemann, Volker V; Stintzing, Sebastian S; Lindoerfer, Doris D; Mansmann, Ulrich U; Pohl, Michael M; Teschendorf, Christian C; Bernhardt, Christiane C; Wolters, Heiner H; Stern, Josef J; Usta, Selami S; Viebahn, Richard R; Admard, Jacob J; Casadei, Nicolas N; Fröhling, Stefan S; Ball, Claudia R CR; Siveke, Jens T JT; Glimm, Hanno H; Tannapfel, Andrea A; Schmiegel, Wolff W; Hahn, Stephan A SA
Publication Date: 2021-07-16

Variant appearance in text: EGFR: S492R
PubMed Link: 34271981
Variant Present in the following documents:
  • Main text
  • 13073_2021_Article_926.pdf
View BVdb publication page



Identification and prognostic analysis of the cetuximab resistance-related gene REV1 in RAS wild-type metastatic colorectal cancer.

American Journal Of Cancer Research
Zhu, Ning N; Fang, Xuefeng X; Li, Dan D; Yang, Mengyuan M; Zhu, Lizhen L; Zhong, Liping L; Weng, Shanshan S; Wang, Juan J; Yuan, Ying Y
Publication Date: 2021

Variant appearance in text: EGFR: S492R
PubMed Link: 34249427
Variant Present in the following documents:
  • Main text
View BVdb publication page



EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance.

Cancers
Uribe, Mary Luz ML; Marrocco, Ilaria I; Yarden, Yosef Y
Publication Date: 2021-06-01

Variant appearance in text: EGFR: S492R
PubMed Link: 34206026
Variant Present in the following documents:
  • Main text
  • cancers-13-02748.pdf
View BVdb publication page



Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer.

Nature Ecology & Evolution
Woolston, Andrew A; Barber, Louise J LJ; Griffiths, Beatrice B; Pich, Oriol O; Lopez-Bigas, Nuria N; Matthews, Nik N; Rao, Sheela S; Watkins, David D; Chau, Ian I; Starling, Naureen N; Cunningham, David D; Gerlinger, Marco M
Publication Date: 2021-07

Variant appearance in text: EGFR: S492R
PubMed Link: 34017094
Variant Present in the following documents:
  • Main text
  • EMS123045.pdf
View BVdb publication page



Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA.

Targeted Oncology
Patelli, Giorgio G; Vaghi, Caterina C; Tosi, Federica F; Mauri, Gianluca G; Amatu, Alessio A; Massihnia, Daniela D; Ghezzi, Silvia S; Bonazzina, Erica E; Bencardino, Katia K; Cerea, Giulio G; Siena, Salvatore S; Sartore-Bianchi, Andrea A
Publication Date: 2021-05

Variant appearance in text: EGFR: S492R
PubMed Link: 33738696
Variant Present in the following documents:
  • Main text
View BVdb publication page



Anti-EGFR antibody 528 binds to domain III of EGFR at a site shifted from the cetuximab epitope.

Scientific Reports
Makabe, Koki K; Yokoyama, Takeshi T; Uehara, Shiro S; Uchikubo-Kamo, Tomomi T; Shirouzu, Mikako M; Kimura, Kouki K; Tsumoto, Kouhei K; Asano, Ryutaro R; Tanaka, Yoshikazu Y; Kumagai, Izumi I
Publication Date: 2021-03-11

Variant appearance in text: EGFR: S492R
PubMed Link: 33707468
Variant Present in the following documents:
  • Main text
  • 41598_2021_Article_84171.pdf
View BVdb publication page



Personalized medicine in colorectal cancer.

Gastroenterology And Hepatology From Bed To Bench
Vaseghi Maghvan, Padina P; Jeibouei, Shabnam S; Akbari, Mohammad Esmael ME; Niazi, Vahid V; Karami, Farshid F; Rezvani, Alireza A; Ansarinejad, Nafiseh N; Abbasinia, Masroor M; Sarvari, Gisoo G; Zali, Hakimeh H; Talaie, Ramin R
Publication Date: 2020

Variant appearance in text: EGFR: S492R
PubMed Link: 33585000
Variant Present in the following documents:
  • Main text
  • GHFBB-13-S18.pdf
View BVdb publication page



On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.

Npj Precision Oncology
Moser, Tina T; Waldispuehl-Geigl, Julie J; Belic, Jelena J; Weber, Sabrina S; Zhou, Qing Q; Hasenleithner, Samantha O SO; Graf, Ricarda R; Terzic, Jasmin Alia JA; Posch, Florian F; Sill, Heinz H; Lax, Sigurd S; Kashofer, Karl K; Hoefler, Gerald G; Schoellnast, Helmut H; Heitzer, Ellen E; Geigl, Jochen B JB; Bauernhofer, Thomas T; Speicher, Michael R MR
Publication Date: 2020-11-13

Variant appearance in text: EGFR: S492R
PubMed Link: 33299124
Variant Present in the following documents:
  • Main text
View BVdb publication page



Research and application of single-cell sequencing in tumor heterogeneity and drug resistance of circulating tumor cells.

Biomarker Research
Dai, Zhe Z; Gu, Xu-Yu XY; Xiang, Shou-Yan SY; Gong, Dan-Dan DD; Man, Chang-Feng CF; Fan, Yu Y
Publication Date: 2020-11-10

Variant appearance in text: EGFR: S492R
PubMed Link: 33292625
Variant Present in the following documents:
  • Main text
  • 40364_2020_Article_240.pdf
View BVdb publication page



Tyrosine Kinase Receptors in Oncology.

International Journal Of Molecular Sciences
Esteban-Villarrubia, Jorge J; Soto-Castillo, Juan José JJ; Pozas, Javier J; San Román-Gil, María M; Orejana-Martín, Inmaculada I; Torres-Jiménez, Javier J; Carrato, Alfredo A; Alonso-Gordoa, Teresa T; Molina-Cerrillo, Javier J
Publication Date: 2020-11-12

Variant appearance in text: EGFR: S492R
PubMed Link: 33198314
Variant Present in the following documents:
  • Main text
View BVdb publication page